Atacand: Effective Blood Pressure Control for Cardiovascular Health
| Product dosage: 16mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.41 | $48.19 (0%) | 🛒 Add to cart |
| 30 | $2.01 | $72.29 $60.24 (17%) | 🛒 Add to cart |
| 60 | $1.92 | $144.58 $115.46 (20%) | 🛒 Add to cart |
| 90 | $1.71 | $216.87 $153.62 (29%) | 🛒 Add to cart |
| 120 | $1.57 | $289.16 $188.76 (35%) | 🛒 Add to cart |
| 180 | $1.43 | $433.74 $258.03 (41%) | 🛒 Add to cart |
| 270 | $1.15 | $650.61 $309.24 (52%) | 🛒 Add to cart |
| 360 | $1.07
Best per pill | $867.48 $384.54 (56%) | 🛒 Add to cart |
| Product dosage: 4mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.47 | $44.18 (0%) | 🛒 Add to cart |
| 60 | $1.17 | $88.35 $70.28 (20%) | 🛒 Add to cart |
| 90 | $0.93 | $132.53 $83.33 (37%) | 🛒 Add to cart |
| 120 | $0.89 | $176.71 $106.43 (40%) | 🛒 Add to cart |
| 180 | $0.85 | $265.06 $152.61 (42%) | 🛒 Add to cart |
| 270 | $0.81 | $397.59 $218.88 (45%) | 🛒 Add to cart |
| 360 | $0.76
Best per pill | $530.12 $275.10 (48%) | 🛒 Add to cart |
| Product dosage: 8mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.11 | $42.17 (0%) | 🛒 Add to cart |
| 30 | $1.81 | $63.25 $54.22 (14%) | 🛒 Add to cart |
| 60 | $1.39 | $126.51 $83.33 (34%) | 🛒 Add to cart |
| 90 | $1.26 | $189.76 $113.45 (40%) | 🛒 Add to cart |
| 120 | $1.20 | $253.01 $143.58 (43%) | 🛒 Add to cart |
| 180 | $1.13 | $379.52 $203.82 (46%) | 🛒 Add to cart |
| 270 | $0.96 | $569.28 $258.03 (55%) | 🛒 Add to cart |
| 360 | $0.93
Best per pill | $759.04 $336.35 (56%) | 🛒 Add to cart |
Synonyms | |||
Atacand (candesartan cilexetil) is an angiotensin II receptor blocker (ARB) prescribed for the management of hypertension and heart failure. It works by blocking the action of certain natural substances that tighten blood vessels, allowing blood to flow more smoothly and the heart to pump more efficiently. This medication is trusted by healthcare professionals for its efficacy in lowering blood pressure and reducing the risk of cardiovascular events in appropriate patient populations. Consistent use as directed can contribute to long-term vascular health and improved quality of life.
Features
- Active ingredient: Candesartan cilexetil
- Available in tablet form (4 mg, 8 mg, 16 mg, 32 mg strengths)
- Once-daily dosing for patient convenience
- Selective angiotensin II type 1 (AT1) receptor blockade
- FDA-approved for hypertension and heart failure (NYHA Class II-IV)
- Bioavailability approximately 15%, with peak plasma concentration reached within 3–4 hours
Benefits
- Effectively lowers high blood pressure, reducing strain on the heart and arteries
- Decreases the risk of stroke, heart attack, and kidney problems associated with hypertension
- Improves survival and reduces hospitalizations in patients with heart failure
- Well-tolerated profile with a low incidence of side effects like cough compared to ACE inhibitors
- Supports long-term cardiovascular protection when used as part of a comprehensive treatment plan
- Once-daily dosing supports adherence and consistent blood pressure control
Common use
Atacand is commonly prescribed for the treatment of hypertension (high blood pressure) in adults and children over 1 year of age. It is also used in adult patients for the treatment of heart failure (New York Heart Association Class II-IV) when ACE inhibitors are not suitable or in combination with other heart failure therapies. In some cases, it may be used off-label for renal protection in diabetic nephropathy, though this use should be strictly supervised by a healthcare provider.
Dosage and direction
For hypertension in adults: The usual starting dose is 16 mg once daily, which may be increased to 32 mg once daily based on blood pressure response. Dosage may be administered with or without food.
For hypertension in pediatric patients (1 to <17 years): Dose is based on body weight. For patients weighing >50 kg, the recommended starting dose is 8-16 mg once daily, with possible titration to 32 mg daily.
For heart failure: The recommended starting dose is 4 mg once daily, which should be doubled at intervals of at least 2 weeks to a target maintenance dose of 32 mg once daily, as tolerated.
Dosage adjustments are necessary for patients with hepatic impairment or renal impairment. The maximum recommended dose is 32 mg daily.
Precautions
- Regular monitoring of blood pressure, renal function, and electrolytes (particularly potassium) is recommended during treatment.
- Use with caution in patients with renal artery stenosis, as there is risk of increased serum creatinine and blood urea nitrogen (BUN).
- Volume-depleted patients (e.g., those on diuretic therapy) should be corrected prior to administration to avoid symptomatic hypotension.
- Not recommended during pregnancy due to potential risk of fetal injury or death; discontinue if pregnancy is detected.
- Use with caution in patients with severe congestive heart failure, as they may be particularly sensitive to changes in renal function.
- Avoid use in patients with biliary obstruction disorders, as candesartan is extensively excreted in bile.
Contraindications
- Hypersensitivity to candesartan cilexetil or any component of the formulation.
- Concomitant use with aliskiren in patients with diabetes.
- Pregnancy (second and third trimesters).
- Severe hepatic impairment or biliary cirrhosis or obstruction.
Possible side effect
Common side effects (≥1%):
- Dizziness
- Upper respiratory tract infection
- Back pain
- Pharyngitis
- Rhinitis
Less common but serious side effects:
- Symptomatic hypotension
- Hyperkalemia
- Impaired renal function
- Angioedema (rare)
- Increased liver enzymes
Rare side effects include:
- Leukopenia, neutropenia, agranulocytosis
- Rashes, urticaria, pruritus
- Hyponatremia
Drug interaction
- Potassium supplements, potassium-sparing diuretics, or salt substitutes containing potassium: increased risk of hyperkalemia.
- NSAIDs (e.g., ibuprofen, naproxen): may reduce antihypertensive effect and increase risk of renal impairment.
- Lithium: increased lithium concentrations and toxicity.
- Other antihypertensive agents: additive hypotensive effects.
- Aliskiren: increased risk of renal impairment, hyperkalemia, and hypotension, particularly in patients with diabetes or renal impairment.
- ACE inhibitors: increased risk of hyperkalemia, hypotension, and renal dysfunction.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is nearly time for the next dose, the missed dose should be skipped and the regular dosing schedule resumed. Doubling the dose to make up for a missed dose is not recommended.
Overdose
The most likely manifestation of overdose is hypotension and tachycardia. Bradycardia may also occur. If overdose occurs, supportive treatment should be instituted, including intravenous fluids and vasoconstrictors if necessary. Removal of Atacand by hemodialysis is minimal.
Storage
Store at room temperature (20-25°C or 68-77°F), with excursions permitted between 15-30°C (59-86°F). Keep in the original container, tightly closed, and protect from light and moisture. Keep out of reach of children and pets.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Do not disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
Clinical studies and post-marketing surveillance demonstrate that Atacand is generally well-tolerated and effective for blood pressure control and heart failure management. In the CHARM program, candesartan significantly reduced cardiovascular death and hospitalizations for heart failure. Patient reviews often note consistent blood pressure reduction with minimal side effects, though individual responses may vary. Healthcare providers frequently report satisfaction with its efficacy and tolerability profile, particularly in patients who cannot tolerate ACE inhibitors.